Efficacy and safety of molnupiravir in adult outpatients with COVID-19
Background: One of the basic principles for the treatment of COVID-19 patients is the early initiation of etiotropic therapy. The evidence base for assessment of the efficacy and safety of antivirals for COVID-19 continues to expand with new clinical trials. One of the promising etiotropic medicatio...
Main Authors: | Natalia Y. Pshenichnaya, Khadizhat G. Omarova, Larisa A. Balykova, Kira Y. Zaslavskaya, Dmitry N. Zemskov, Aleхey V. Taganov, Petr A. Belyy, Aleksandr V. Gorelov, Dmitry Y. Pushkar |
---|---|
Format: | Article |
Language: | Russian |
Published: |
MONIKI
2023-06-01
|
Series: | Alʹmanah Kliničeskoj Mediciny |
Subjects: | |
Online Access: | https://almclinmed.ru/jour/article/viewFile/8518/1566 |
Similar Items
-
Phase I Pharmacokinetics Study of Oral Administration of Esperavir® (INN: Molnupiravir) (LLC "PROMOMED RUS", Russia)
by: T. N. Komarov, et al.
Published: (2024-03-01) -
Reciprocal Impact of Molnupiravir and Favipiravir Monocomponents of the Combination Drug on Each Other's Pharmacokinetics in a Phase I Clinical Trial
by: T. N. Komarov, et al.
Published: (2024-03-01) -
Safety and Effectiveness of Molnupiravir in Covid-19 Treatment: A Rapid Review
by: Mohammadreza Mobinizadeh, et al.
Published: (2022-10-01) -
BIOEQUIVALENCE STUDY OF GENERIC MOLNUPIRAVIR IN HEALTHY VOLUNTEERS
by: V. B. Vasilyuk, et al.
Published: (2023-02-01) -
Molnupiravir for the treatment of COVID-19 outpatients: An updated meta-analysis
by: Huzaifa Ahmad Cheema, et al.
Published: (2024-06-01)